Switch to: Citations

Add references

You must login to add references.
  1. The Haunting of Medical Journals.Adriane Fugh-Berman - 2010 - Plos Medicine 7 (9):e1000335.
    Summary Points -/- Some 1500 documents revealed in litigation provide unprecedented insights into how pharmaceutical companies promote drugs, including the use of vendors to produce ghostwritten manuscripts and place them into medical journals. Dozens of ghostwritten reviews and commentaries published in medical journals and supplements were used to promote unproven benefits and downplay harms of menopausal hormone therapy (HT), and to cast raloxifene and other competing therapies in a negative light. Specifically, the pharmaceutical company Wyeth used ghostwritten articles to mitigate (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • Guest Authorship and Ghostwriting in Publications Related to Rofecoxib.Joseph Ross, Kevin Hill, David Egilman & Harlan Krumholz - 2008 - Journal of the American Medical Association 299 (15):1800-12.
    Download  
     
    Export citation  
     
    Bookmark   20 citations  
  • Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
    Pharmaceutical companies fund the bulk of clinical research that is carried out on medications. Poor outcomes from these studies can have negative effects on sales of medicines. Previous research has shown that company funded research is much more likely to yield positive outcomes than research with any other sponsorship. The aim of this article is to investigate the possible ways in which bias can be introduced into research outcomes by drawing on concrete examples from the published literature. Poorer methodology in (...)
    Download  
     
    Export citation  
     
    Bookmark   22 citations  
  • Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry?Sergio Sismondo - manuscript
    Anecdotes have shown that some articles on profitable drugs are constructed by and shepherded through publication by pharmaceutical companies and their agents, whose influence is largely invisible to readers. This is ghost-management, the substantial but unrecognized research, analysis, writing, editing and/or facilitation behind publication. Publicly available documents suggest that these practices extremely widespread affecting up to 40% of clinical trial reports in key periods but it has been unclear how representative these documents are. This article presents the results of an (...)
    Download  
     
    Export citation  
     
    Bookmark   31 citations  
  • Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light on.Sergio Sismondo - 2013 - Journal of Law, Medicine and Ethics 41 (3):635-643.
    The pharmaceutical industry, in its marketing efforts, often turns to “key opinion leaders” or “KOLs” to disseminate scientific information. Drawing on the author's fieldwork, this article documents and examines the use of KOLs in pharmaceutical companies’ marketing efforts. Partly due to the use of KOLs, a small number of companies with well-defined and narrow interests have inordinate influence over how medical knowledge is produced, circulated, and consumed. The issue here, as in many other cases of institutional corruption, is that a (...)
    Download  
     
    Export citation  
     
    Bookmark   23 citations  
  • A proposal for a new system of credit allocation in science.David B. Resnik - 1997 - Science and Engineering Ethics 3 (3):237-243.
    This essay discusses some of the problems with current authorship practices and puts forward a proposal for a new system of credit allocation: in published works, scientists should more clearly define the responsibilities and contributions of members of research teams and should distinguish between different roles, such as author, statistican, technician, grant writer, data collector, and so forth.
    Download  
     
    Export citation  
     
    Bookmark   21 citations  
  • The Paroxetine 352 Bipolar Trial: A Study in Medical Ghostwriting.Leemon McHenry & Jay Amsterdam - 2012 - International Journal of Risk and Safety in Medicine 24 (4):221-231.
    The problem of ghostwriting in corporate-sponsored clinical trials is of concern to medicine, bioethics, and government agencies. We present a study of the ghostwritten archival report of an industry-sponsored trial comparing antidepressant treatments for bipolar depression: GlaxoSmithKline (GSK) paroxetine study 352.
    Download  
     
    Export citation  
     
    Bookmark   2 citations